US Stock MarketDetailed Quotes
IHE Ishares Trust U.S. Pharmaceuticals Etf
- 64.830
- -0.200-0.31%
Close May 2 16:00 ET
65.360High64.750Low
65.360High64.750Low19.78KVolume65.360Open65.030Pre Close1.28MTurnover0.19%Turnover Ratio--P/E (Static)10.20MShares69.27552wk High--P/B661.27MFloat Cap55.01452wk Low0.91Dividend TTM10.20MShs Float69.275Historical High1.40%Div YieldTTM0.94%Amplitude21.642Historical Low64.954Avg Price1Lot Size
Is anybody riding this wave with me?
$Invesco Pharmaceuticals ETF(PJP.US)$$Ishares Trust U.S. Pharmaceuticals Etf(IHE.US)$$Spdr Series Trust Spdr S&P Pharmaceuticals Etf(XPH.US)$
$SPDR S&P Biotech ETF(XBI.US)$$VanEck Biotech ETF(BBH.US)$
My long term investment review
Are you looking at a specific industry/market/asset type? Why?
What is your latest fund investment plan? What are the reasons behind it?
The current macro conditions (high inflation, FED rate hike and recession) have crippled our will to invest in long term. In my previous post, I reveal plan to invest in long term to position myself when the economy recover hopefully by ...
ColumnsWeekly FDA Drug Pipeline Calendar (Oct 10- Oct 13)
$AbbVie(ABBV.US)$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
$Protagonist Therapeutics(PTGX.US)$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis
$PTC Therapeutics(PTCT.US)$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022
$Scholar Rock(SRRK.US)$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Follow for more insights and top news for pharmacy industry!
No comment yet